2-Aminoethyl diphenylborinate (2-APB) 1 was recently identified as a chemical activator of TRPV1, TRPV2 and TRPV3, three heat-gated members of the transient receptor potential vanilloid ion channel subfamily. Here, we demonstrate that two structurally related compounds, diphenylboronic anhydride ( D P B A ) a n d diphenyltetrahydrofuran (DPTHF), can also modulate the activity of these channels. DPBA acts as a TRPV3 agonist, whereas DPTHF exhibits prominent antagonistic activity. However, all three diphenyl-containing compounds promote some degree of channel activation or potentiation, followed by channel block. Strong TRPV3 activation by DPBA often leads to the appearance of a secondary, enhanced, current phase. A similar biphasic response is observed during TRPV3 heat stimulation; an initial, gradually sensitizing phase (I 1 ) is followed by an abrupt transition to a secondary phase (I 2 ). I 2 is characterized by larger current amplitude, loss of outward rectification, and alterations in the following properties: permeability among cations; ruthenium red and DPTHF sensitivity; temperature-dependence; and voltagedependent gating. The I 1 to I 2 transition depends strongly on TRPV3 current density. Removal of extracellular divalent cations results in heat-evoked currents resembling I 2 , while mutation of a putative Ca 2+ binding residue in the pore loop domain, aspartate 641, facilitates detection of the I 1 to I 2 transition, suggesting that the conversion to I 2 results from the agonist-and time-dependent loss of divalent cationic inhibition. Primary keratinocytes overexpressing exogenous TRPV3 also exhibit biphasic agonist-evoked currents. Thus, strong activation by either chemical or thermal stimuli leads to biphasic TRPV3 signaling behavior that may be associated with changes in the channel pore.
Four members of the transient receptor potential vanilloid (TRPV) protein subfamily have been identified as heat-gated non-selective cation channels. TRPV1 and TRPV2 are activated by noxious heat at temperatures above approximately 42 and 52 °C, respectively (1,2). TRPV3 (3) (4) (5) and TRPV4 (6) are both responsive to temperature changes in the warm range (> 32 °C). These two channels differ, however, in that TRPV3-mediated responses gradually sensitize during constant or repetitive stimulation (3, 5, 7) , whereas responses mediated by TRPV4 desensitize under such conditions (8) . The mechanism(s) by which heat activates these channels is not understood. However, recent findings suggest that, in the case of TRPV1, gating is a thermodynamic process, closely linked to this channel's voltage dependence (9) .
In addition to heat, all four of these channels can alternatively be activated by synthetic or naturally occurring chemical stimuli. TRPV1, for example, can be activated by pungent vanilloid compounds (e.g., capsaicin, resiniferatoxin), protons, or certain endocannabinoid lipids (10) . TRPV4, in contrast, can be activated by the synthetic phorbol ester, 4 α -phorbol didecanoate, or by 5′, 6′ epoxyeicosatrienoic acid, a cytochrome P450 metabolite of arachidonic acid (11) . Recently, another small organic molecule, 2-aminoethyl diphenylborinate (2-APB) was shown to activate TRPV3, both in heterologous expression systems and in keratinocytes expressing this channel endogenously (12, 13) . At higher concentrations, this same compound can activate TRPV1 and TRPV2, but not TRPV4 (13) .
2-APB was initially demonstrated to act as an inhibitor of inositol 1,4,5-triphosphate (IP 3 ) induced Ca 2+ release from intracellular stores (14) . Subsequent studies revealed that this compound could also block store-operated calcium entry, which is believed by some investigators to be mediated by TRP channels (15) , independent of IP 3 receptors, and that under certain circumstances, it could paradoxically potentiate both of these activities (16) (17) (18) (19) (20) (21) (22) . In addition, 2-APB has been reported to activate an unidentified nonselective cation channel in RBL-2H3 m1 rat basophilic leukemia cells (23) and to inhibit volumeregulated anion channels (24) .
Two structural analogs of 2-APB, diphenylboronic anhydride (DPBA) and 2,2-diphenyltetrahydrofuran (DPTHF), have also been reported to inhibit store operated calcium entry (18) . However, the activity profiles of these compounds are not identical. For example, whereas 2-APB inhibits volume-regulated anion channels, DPTHF apparently does not (24) . Given these findings, we sought to determine whether and how DPBA and DPTHF might modulate TRPV3 activity.
Here, we report that, like 2-APB, DPBA activates recombinant TRPV3. In contrast, DPTHF inhibits TRPV3 activation by either of these compounds. We also find that repetitive or prolonged activation of TRPV3 with either DPBA or heat evokes not only an initial phase, consisting of gradually sensitizing, outwardly rectifying currents, but also a subsequent phase, characterized by a much higher current amplitude and absence of outward rectification. Further analysis reveals that changes in both voltagedependent gating and divalent cation block may contribute to these time-dependent changes in heat-evoked TRPV3 currents.
EXPERIMENTAL PROCEDURES
DNA constructs, cell culture and transfections -Unless otherwise noted, molecular biology and cell culture reagents were obtained from Invitrogen (Carlsbad, CA) or New England Biolabs (Beverly, MA) and chemicals from Sigma (St. Louis, MO). Cell culture and transfection with Lipofectamine 2000 (Invitrogen), were performed as previously described (6) . A TRPV3-YFP cDNA encoding mouse TRPV3 (25) with yellow fluorescent protein (YFP) fused onto its Cterminus was subcloned into pcDNA3 (Invitrogen) and transfected into Human Embryonic Kidney (HEK) 293 cells (gift of J. Nathans, Johns Hopkins University). A single G418 (500 µg/ml)-resistant clone exhibiting a high level of YFP fluorescence and TRPV3 immunoreactivity was used for Ca 2+ imaging studies. Stable transfectants of rat TRPV1, rat TRPV4, and pcDNA3 alone have been described previously (6) .
HEK 293 cells expressing SV40 large T-antigen were transiently co-transfected with cDNA encoding mouse TRPV2 (25) or pcDNA3 and green fluorescent protein (GFP). For whole-cell voltage clamp experiments, HEK 293/T-antigen cells were transiently transfected with the mammalian expression vector, pTracer (Invitrogen) or pcDNA3 containing mouse TRPV3 cDNA. In TRPV3-pTracer, TRPV3 expression is driven by a cytomegalovirus promoter and GFP-Zeocin expression by an EM-7 promoter. pTracer without TRPV3 was used for vector control experiments. Site-directed mutagenesis of TRPV3 was performed by the polymerase chain reaction using complementary synthetic oligonucleotides encoding the mutation of interest and Proofstart high-fidelity polymerase (Qiagen, Valencia, CA). The resulting cDNA, subcloned into pcDNA3, was co-tranfected with GFP. Cells were replated 15 to 18 hr post-transfection on polyornithine-coated glass coverslips and subjected to patch clamp recording 2 hr later. Transiently transfected cells were identified by GFP fluorescence.
For most experiments, primary keratinocytes were cultured from newborn mice (postnatal day 1-3) as previously described (12, 26) , plated at 10 5 /cm 2 on uncoated glass cover slips, and assayed after 40~80 hrs at 37 °C/5% CO 2 . In several cases, we used an alternative protocol incorporating 2.5% dispase instead of trypsin, in an effort to increase the expression level of native TRPV3. In this protocol, cells collected after proteolysis were centrifuged through a bovine serum albumin column (3g/20 ml media), then resuspended and cultured in Serum-F r e e Keratinocyte Medium (Invitrogen) supplemented with 50 µg/ml bovine pituitary extract, 5 ng/ml epidermal growth factor and 0.05 mM CaCl 2 . The cells were plated on polyornithine/laminin/collagen IV-coated coverslips and recorded after 40-60 hrs. Keratinocyte transfection was performed 24 hours after cell plating using Lipofectamine 2000 (Invitrogen) and voltage clamp performed after an additional 18 hours. Ca 2+ imaging -Ca 2+ imaging bath solution contained (in mM) 130 NaCl, 3 KCl, 2.5 CaCl 2 , 0.6 MgCl 2 , 10 HEPES, 1.2 NaHCO 3 and 10 glucose, adjusted to pH 7.45 with NaOH. Cells were loaded with fura 2-AM as described previously (6) . Ratiometric Ca 2+ imaging was performed using an upright fluorescence microscope (Nikon, Melville, NY), excitation filter changer (Ludl, Hawethorne, NY), and CCD camera (Coolsnap ES, Roper, Tuscon, AZ). Pairwise images (340 and 380 nm excitation, 510 nm emission) were collected at 2 to 10 second intervals and the data analyzed using Ratio Tool software (Isee Imaging, Rahleigh, NC) as previously described (6) . For 50 cells from each coverslip, fura ratios (emission at 340nm excitation/emission at 380 nm excitation) were calculated, baseline-subtracted and averaged. Data from ≥ 4 independent coverslips were used to calculate mean ± SEM for each experimental group.
Patch-clamp electrophysiology -Unless otherwise indicated, in whole-cell voltage clamp experiments using 2-APB, DPBA or DPTHF, recording pipettes were filled with "low-Cl -pipette solution" containing (in mM) 120 Cs-Aspartate, 10 CsCl, 1 MgCl 2 , 5 EGTA, and 10 HEPES (pH 7.4 with CsOH). Cells were superfused with "low-Cl -bath solution" containing (in mM) 130 Na-Aspartate, 6 NaCl, 2 CaCl 2 , 1 MgCl 2 , 10 glucose, 10 HEPES (pH 7.4 with NaOH). Standard bath solution for recording heat-evoked currents contained (in mM) 140 NaCl, 10 glucose, 1 CaCl 2 , 0.5 MgCl 2 , 10 HEPES (pH 7.4 with NaOH). Standard pipette solution contained (in mM) 140 NaCl, 10 HEPES, 5 EGTA (pH 7.4 with NaOH). In the experiment evaluating the voltagedependence of heat-evoked currents, NaCl in the bath and pipette solutions was reduced from 140 mM to 40 mM with equimolar substitution of Nmethyl d-glucamine (NMDG) to minimize the series resistance error derived from the large current amplitudes. To evaluate the relative permeabilities of NMDG and Ca 2+ to Na + , we first measured the reversal potential (E rev ) using a bath solution containing 140 NaCl, 10 HEPES (pH 7.4 with NaOH) combined with the standard pipette solution. Then we measured the E rev change using a solution containing 140 NMDG-Cl, 10 HEPES (pH 7.4 with HCl) for NMDG permeability, or 140 NaCl, 5 CaCl 2 , 10 HEPES (pH 7.4 with NaOH) for Ca 2+ permeability. Unless otherwise indicated, keratinocytes were recorded in whole-cell voltageclamp mode using pipette solution containing (in mM) 140 CsCl, 1 MgCl 2 , 10 HEPES, 5 EGTA (pH 7.4 with CsOH) and the standard bath solution.
An Axopatch 200B or Multiclamp 700A amplifier was used with pClamp 9 software (Axon Instruments, Union City, CA). Borosilicate glass electrodes had tip resistances of 2-4 MΩ . The series resistance was usually in the range of 4 to 7 MΩ, which was not compensated. Recording was aborted if this value exceeded 10 MΩ . In the experiment evaluating voltage-dependence, series resistance compensation was performed to ~75%. A 3 M KCl agar salt bridge was used throughout the experiments. Bath temperature was controlled using an in-line heater, alone or together with an in-line heater/cooler (Warner Instruments, Hamden, CT) and monitored continuously with a thermistor (Physitemp, Clifton, NJ). The bath was perfused throughout the experiment and drug and temperature stimulus application was performed using an automated valve manifold (Warner Instruments, Hamden, CT or Automate Scientific Inc, San Francisco, CA).
Data Analysis -Data are expressed as mean ± SEM.
Unless otherwise indicated, statistical comparisons were made using unpaired Student's t test. Concentration-response relations were fitted using Prism software (Graphpad, San Diego, CA) with the following equations: y = E max /(1+(EC 50 /x) H ) for 2-APB and DPBA or y = I max /(1+ (IC 50 /x) H ) for DPTHF, where E max or I max is maximal agonistic or inhibitory effect, respectively, x is agonist or antagonist concentration, H is the Hill coefficient, E C 50 or IC 50 is half-maximal effective concentration for activation or inhibition, respectively. In the case of DPTHF, separate fits were conducted from 1 µM to 32 µM, and from 32 µM to 1 mM. Linear regression fits (y = mx + b, where m is the slope) were achieved with pClampfit 9 (Axon Instruments) or Prism software. Curves plotting the relationship between voltage and tail current amplitude were fitted using the Boltzmann equation : I=I min + (I max -I min )/(1+exp((V 1/2 -V)/k)), where I min is the minimum current amplitude, I max is the maximum current amplitude, V 1/2 is the potential at which I is halfway between I min and I max , and k is the slope.
To calculate cationic permeabilities relative to Na + , we used the following equations: P NMDG /P Na = exp((F/RT)(E NMDG -E Na )), and P Ca /P Na = {[Na + ]/4[Ca 2+ ] } { e x p ( (F/RT)(E Ca -E Na ))-1} {1+exp(E Ca (F/RT))}, where, P is the permeability of the indicated ion , F is Faraday's constant, R is the gas constant, T is absolute temperature, and E is the reversal potential for the ion indicated by the subscript, corrected for liquid junction potential calculated in pClamp 9.
RESULTS
To explore the effects of 2-APB structural analogs on TRPV3, we performed fura 2 microscopic fluorescent Ca 2+ imaging on HEK 293 cells stably expressing mouse TRPV3 bearing a C terminal yellow fluorescent protein tag (TRPV3-YFP). DPBA (100 µM, Fig. 1A , C), like 2-APB (100 µ M, Fig. 1A, B) , evoked robust free intracellular Ca 2+ concentration ([Ca 2+ ] i ) increases in these cells at room temperature that reversed upon washout (mean change in fura 340 nm/380 nm excitation ratio, 0.73 ± 0.07 units, n = 7 coverslips). No such responses were observed in cells stably transfected with the control vector pcDNA3 (0.02 ± 0.01 fura ratio units, n = 4 coverslips, p < 10 -4 versus TRPV3-YFP, unpaired Student's t test) or in TRPV3-YFP cells treated with vehicle alone (0.1% DMSO, not shown). In contrast to the other two compounds, DPTHF (100 µM) failed to evoke a detectable increase in [Ca 2+ ] i in cells expressing TRPV3-YFP. However, in the presence of DPTHF, responses to 100 µM 2-APB were reduced by 73.2% (0.18 ± 0.01 ratio units, n = 4, versus 0.65 ± 0.13 ratio units, n = 8 in the absence of DPTHF, p < 0.01, Fig. 1A, B) . DPTHF also produced a robust (93.2%) inhibition of 100 µM DPBA-induced responses (0.05 ± 0.02 ratio units, n = 6, p < 10 -5 versus DPBA alone, Fig. 1A , C). Reportedly, TRPV1 and TRPV2 can also be activated by higher concentrations of 2-APB, whereas TRPV4 cannot (12, 13) . Confirming these results, upon stimulation with 320 µM of 2-APB, we observed a strong rise in [Ca 2+ ] i in HEK 293 cells stably expressing rat TRPV1 (1.36 ± 0.10 ratio units, p < 0.001 versus pcDNA3 control, n = 4) or transiently expressing rat TRPV2 (0.58 ± 0.04 ratio units p < 0.01 versus pcDNA3 control, n = 4) (Fig. 1B) . Therefore, we tested whether DPBA or DPTHF could activate or inhibit these other channels. DPBA (100 µM) evoked a robust rise in [Ca 2+ ] i in TRPV1-(0.77 ± 0.06 ratio units, n = 8, p < 10 -6 versus pcDNA3 control, n = 4) or TRPV2-expressing cells (0.99 ± 0.03, n = 4, p < 10 -4 versus pcDNA3 control, n = 4) (Fig. 1A, C) . In HEK 293 cells stably expressing rat TRPV4, even at 500 µM, DPBA failed to evoke [Ca 2+ ] i increases distinguishable from the small background responses of stable pcDNA3 transfectants (Fig. 1A, C) . When DPTHF (100 µM) was included in the bath solution during DPBA stimulation of TRPV1-or TRPV2-expressing cells, the sizes of the responses were not altered significantly (data not shown). However, at a higher concentration (500 µM) DPTHF produced a modest inhibition of these channels (TRPV1, 25.2% inhibition, n = 4, p < 0.05; TRPV2, 33.2% inhibition, n = 4, p < 0.001), (Fig. 1A, C) . Given the relatively limited DPTHF activity at these two channels, we focused our subsequent analyses on TRPV3.
In order to confirm that TRPV3 can be activated by DPBA and that this activity is inhibited by DPTHF, we performed whole-cell voltage clamp experiments on wild-type mouse TRPV3 transiently transfected into HEK 293 cells. In these cells, both 2-APB and DPBA evoked robust currents with E rev near 0 mV in currentvoltage (I-V) traces ( Fig. 2A, B, F, G) . In both cases, response amplitudes increased and outwardly rectifying initial responses became dually rectifying with successive drug applications. No such current responses were observed in cells transiently transfected with the control vector, pTracer (-3.7 ± 1.4 pA/pF at +80 mV and 0.2 ± 0.2 pA/pF at -80 mV, n = 5 versus TRPV3 expressing cells 247.2 ± 33.7 pA/pF at +80 mV and -59.1 ± 8.9 pA/pF at -80 mV, n = 23, p < 10 -5 ). Likewise, inclusion of DPBA (100 µM) in the pipette resulted in no detectable current increase in cells expressing TRPV3 (data not shown), suggesting an extracellular site of action for this drug, as reported previously for 2-APB (13) . As in the Ca 2+ imaging assay, both 2-APBand DPBA-evoked currents were reversibly inhibited by DPTHF (2-APB, 50.7% and 81.4% inhibition; DPBA, 58.9% and 90.8% inhibition at +80 and -80 mV, respectively, n = 6 to 11) (Fig.  2C, D, F, G) . The DPBA-evoked inward current response was also robustly inhibited by 10 µM ruthenium red (RR; 99% less than control at -80 mV, p < 0.0001, n = 6), an organic cation known to block influx through many cation channels, including most TRPV subtypes (Fig. 2E, G) . However, as previously reported (12) , RR alone evoked outward currents in TRPV3-expressing cells. Moreover, DPBA-evoked outward currents were inhibited only slightly by the presence of this compound (24.5% less than control at +80 mV, p < 0.05, n = 6).
To characterize DPBA-evoked TRPV3 responses more quantitatively, we applied varying concentrations of 2-APB or DPBA for 2 minutes to cells transiently expressing TRPV3 and plotted the maximal current amplitude during the stimulus at ± 80 mV (Fig. 3A) . Responses to each compound were evident at concentrations as low as 10 µM. With increasing concentration, the rising phase of these responses became steeper and the plateau higher. Careful inspection of the resulting concentration-response profiles (Fig. 3B) revealed that, at low concentrations, currents evoked by 2-APB and DPBA were similar in amplitude. However, at 100 µM, responses to DPBA (336.1 ± 29.1 pA/pF at +80 mV and -188.9 ± 24.7 pA/pF at -80 mV) were significantly larger than those to 2-APB (166.0 ± 58.7 pA/pF at +80 mV and -67.5 ± 35.7 pA/pF at -80 mV, n = 9, p < 0.05). Above 100 µM, DPBA-evoked responses tended to reach an apex, then decline in midresponse (Fig. 3A) . This effect became more evident with increasing concentrations of DPBA, and led to an apparent decline in maximal current amplitude at 1 mM. This decline in response amplitude was also observed in 2-APB-treated cells, but only at 1 mM. To minimize the impact of this phenomenon on our estimate of drug potency, we excluded the 1 mM DPBA data point during curve-fitting. To investigate further the inhibition of TRPV3 by DPTHF, we applied 100 µM DPBA to cells expressing TRPV3, allowed responses to reach steady state, then superimposed varying concentrations of DPTHF (Fig. 3C ). Under these conditions, DPTHF concentration-dependently inhibited DPBA-evoked currents. However, this concentration-dependence extended over several orders of magnitude, with two apparent kinetic components (Fig. 3D) . Accordingly, we fitted the response profiles at +80 mV and -80mV with two separate curves each, using 32 µM (10 -4.5 in Fig.  3D To further analyze DPBA-evoked TRPV3 responses, we applied sequentially increasing concentrations of DPBA to a given TRPV3-expressing cell (Fig. 4A-C) . DPBA evoked currents in a concentration-dependent manner (EC 50 = 38.8 µM at +80 mV, 95% CI 18.4 to 82.0 µM; and EC 50 = 38.7 µM at -80 mV, 95% CI 24.7 to 60.6 µM; Hill coefficients, 2.13 at +80 mV and 1.93 at -80 mV). These values are similar to those obtained in the single-concentration protocol, with a slight difference in EC 50 only at -80 mV. Using the increasing-concentration protocol, a midstimulus current decline again became apparent at around 320 µM (20 ± 4% inhibition at +80 mV and 42 ± 6% inhibition at -80 mV, n = 8 cells, Fig.  4D ). After the current reached a plateau, a further increase in DPBA concentration to 1 mM caused a further reduction in current amplitude. Upon drug washout, current amplitude abruptly increased beyond the maximal level achieved in the presence of the drug (Fig. 4A , time-point e; Fig. 4C , filled symbol at 1 mM), followed by a slow reversal towards baseline. This pattern of concentrationdependent desensitization with rapid amplitude increase on drug washout is highly suggestive of DPBA-mediated channel block following strong channel activation.
In 8 out of 13 cells, desensitization to DPBA was immediately preceded by an abrupt increase in current (Fig. 4A , time-point d). While an increase was noted in both inward and outward currents, it was more prominent in the inward direction. To further characterize this apparently multiphasic behavior, we performed linear regression on the current response before and during the steep secondary increase, as demonstrated in Fig. 4E . Comparison of the slopes derived from these two phases revealed significant differences in both inward and outward currents (initial phase: 2.1 ± 0.5 (pA/pF)/sec at +80 mV and -2.5 ± 0.8 (pA/pF)/sec at -80 mV; secondary phase: 4.9 ± 1.1 (pA/pF)/sec at +80 mV and -7.5 ± 1.7 (pA/pF)/sec at -80 mV, n = 8, p < 0.05).
Upon exposure to a single 320 µ M application of DPBA (Fig. 5A, B) , in 45 out of 106 cells (43%), drug application evoked large rapidly desensitizing responses that resembled those seen in the previous experiment. Similarly, during drug washout, these cells demonstrated large residual inward and outward currents with an apparently linear I-V relationship (Fig. 5A , E, point d). However, the rest of the cells exhibited neither desensitizing DPBA-evoked currents nor robust, linear washout currents (Fig. 8D , F, point a). To better understand DPBA-evoked currents following the biphasic current transition, we replaced extracellular cations with NMDG or included 10 µM RR in the bath 30 seconds after the beginning of the DPBA stimulation, and again 90 seconds after drug washout, and analyzed the results from cells that demonstrated clear multiphasic behavior (i.e., desensitization upon DPBA stimulation followed by robust, linear washout currents, Fig. 5A , B). NMDG, added during DPBA stimulation, inhibited currents at -80 mV by 88.4 ± 2.7% (p < 0.05, n = 5, paired t test), while shifting E rev in the hyperpolarizing direction by 28.2 ± 1.3 mV (Fig. 5A , C, E, point c). After drug washout, NMDG inhibited residual currents at -80 mV by 84.5 ± 9.5% (p < 0.05, n = 5, paired t test) and hyperpolarized E rev by 18.4 ± 3.4 mV (Fig. 5A , C, point f). When 10 µM RR was included in the normal bath solution during DPBA stimulation or after washout, the current at -80 mV was inhibited by 101.5 ± 3.1% (p < 0.001, n = 5, paired t test; Fig. 5B , D, F, point c) and 105.0 ± 6.0% at -80mV (p < 0.01, n = 5, paired t test; Fig. 5B , D, F, point f), respectively. Thus, the complex current responses observed in TRPV3-expressing cells following exposure to high concentrations of DPBA are likely to reflect the activity of a RR-sensitive cation channel, as opposed to leak currents or recording artifacts. Moreover, they suggest that, under these conditions, TRPV3 undergoes both a secondary phase of activation and channel block.
The apparently biphasic activation of TRPV3 by high concentrations of DPBA prompted us to investigate whether a similar phenomenon might occur during thermal, as opposed to chemical, activation. As described previously (3-5), naive TRPV3-transfected cells exposed to a 43 to 45 °C bath temperature typically exhibited currents with strong outward rectification that increased gradually in amplitude during two consecutive heat stimuli, but reverted completely to baseline upon return to room temperature (Fig. 6A) . During a subsequent prolonged heat stimulus, the currents initially continued to sensitize at a gradual rate. In many cases, however, at some point during the constant stimulus, the currents exhibited an abrupt increase in both inward and outward amplitude (Fig. 6A , point c). Within a short time, such currents reached a new and relatively stable plateau level. The mean current densities after this transition were -1062 ± 115 pA/pF and 1052 ± 116 pA/pF (n = 11) at -80 and +80 mV, respectively, significantly greater than those measured just before the transition (point b in Fig. 6A , -171 ± 19 pA/pF, p < 10 -5 at -80 mV and 712 ± 74 pA/pF, p < 10 -4 at +80 mV, paired t test, n = 11). During this transition, the rate of current increase accelerated transiently from 3.9 ± 0.9 (pA/pF)/sec at +80 mV and -3.3 ± 0.6 (pA/pF)/sec at -80 mV (n = 7) to 47.3 ± 10.1 (pA/pF)/sec at +80 mV and -136.7 ± 21.8 (pA/pF)/sec at -80 mV (n = 7, p < 0.001 for inward and p < 0.005 for outward currents, paired t test), comparable to the abrupt current enhancement observed during stimulation with high concentrations of DPBA. These changes in amplitude were accompanied by corresponding changes in TRPV3 rectification properties. During the initial gradual sensitization, the rectification ratio (current at +80 mV/current at -80 mV) gradually declined from 12.2 ± 1.3 (n = 13) during the 1 st heat stimulus to 9.5 ± 1.4 (n = 13) during the 2 nd heat stimulus to 6.7 ± 1.1 s (n = 13) after 30s of a 3 rd , prolonged, heat stimulus. By the time the abrupt increase in current amplitude began, the rectification ratio had reached 4.5 ± 0.6 (n = 13). During the ensuing precipitous rise in the rate of current increase, there was a correspondingly rapid decrease in rectification ratio to a value of 1.0 ± 0.01 (n =13) by the time the current reached its new plateau. Synchronization of traces from multiple cells at the point of I-V linearization revealed a rapid and extremely uniform sigmoidal decrease in rectification ratio over time. Indeed, this transition went from 10% to 90% completion in just 10.4 ± 2.4 s (Fig. 6B , n = 13). Thus, both DPBA and heat are able to evoke biphasic TRPV3 activity. For simplicity, we named the initial heat-evoked current component I 1 and the secondary heatevoked current component I 2 .
Although the progression of the I 2 conversion, once initiated, was uniform, the latency to initiation of this conversion was extremely variable between cells. Some cells exhibited this conversion during one of the first few heat stimuli, while some showed no conversion at all (Fig. 6C ). Under the protocol described above, 41% of cells (11 out of 27) showed an I 2 conversion within 2 minutes after initiation of the third heat stimulus. Direct comparison revealed that cells exhibiting an I 2 conversion during the third heat stimulus had a mean current density (current amplitude recorded just prior to I 2 , divided by membrane capacitance) of 696.6 ± 33.7 pA/pF at +80 mV and -149.5 ± 18.7 pA/pF at -80 mV, which was significantly larger than that of cells that did not undergo an I 2 conversion by the end of the third stimulus (326.4 ± 39.2 pA/pF at + 80 mV and -28.9 ± 4.7 pA/pF at -80 mV, maximum current density during the 2-minute third heat stimulus, p < 10 -6 and p < 10 -4 , respectively). In fact, there appeared to be a relative current density threshold for this transition, in that 11/13 cells with a current density greater than 526.4 pA/pF at +80 mV and -87.5 pA/pF at -80 mV (Fig. 6D horizontal dashed lines) entered I 2 , whereas 0/14 cells with a lower current density exhibited this change in response. No I 1 -or I 2 -like currents were observed in pTracer control cells stimulated with heat under the same conditions (n = 10). Thus, the I 2 conversion is dependent on TRPV3 expression and its incidence is associated with a high TRPV3-mediated heatevoked current density.
Further evidence that the I 2 response represents a TRPV3-dependent current, as opposed to heat-induced leak, came from the observation that application of 10 µM RR after the appearance of heat-evoked I 2 eliminated ~92% of I 2 at -80 mV, similar to this compound's inhibition of I 1 at -80 mV (Table 1, Fig. 7A ). However, RR exhibited totally opposite effects on the outward components of heat-evoked I 1 versus I 2 . At +80 mV, RR potentiated I 1 currents by ~80%, but inhibited I 2 by ~80% (Table 1, Fig. 7A ), providing further evidence that I 1 and I 2 are distinct. Given that RR is thought to block TRPV1 and TRPV4 by interacting with the pore region of these channels (27, 28) , we reasoned that the state-dependent change in RR effect on TRPV3 might reflect changes in that channel's pore. We therefore compared I 1 and I 2 with respect to another poredependent channel property, namely cationic permeability (Fig. 7B) . In a nominally divalent cation-free bath solution, a nearly identical E rev of close to 0 mV was observed in both I 1 and I 2 , (Table 1 ) using the protocol shown in Fig. 10A . When external Na + was replaced with NMDG, the current amplitudes at -80 mV were greatly reduced (95.9 ± 6.4%, n = 5, in I 1 ; 76.9 ± 1.9%, n = 12, in I 2 ) and E rev was shifted to negative potentials in both I 1 and I 2 . However, E rev in the presence of NMDG was ~45 mV more hyperpolarized in I 1 than in I 2 , consistent with a 5-fold greater P NMDG /P Na in I 2 (Table 1 ). In the presence of 5 mM Ca 2+ in the bath solution, cells exhibiting a high current density showed a clear I 1 to I 2 transition. During this transition, the E rev shifted noticeably from ~+10 mV to ~+4 mV, consistent with an ~5-fold lower P Ca /P Na in I 2 (Table 1 ). These results demonstrate that I 2 , like I 1 is a RR-sensitive nonselective cationic current. They also strongly suggest that the conversion from I 1 to I 2 signaling behavior reflects changes in the TRPV3 pore.
Taken together, evidence of heat-evoked changes in the TRPV3 pore and evidence of open channel blockade following exposure to high concentrations of DPBA suggested that a common mechanism might underlie strong TRPV3 activation by chemical and thermal stimuli. Moreover, the complex concentration-dependence of DPTHF inhibition of DPBA-evoked responses could, potentially, be explained by the combined effects of competition for the DPBA binding site, and open channel block by DPTHF. If so, DPTHF might be expected to block heat-evoked I 2 , but not I 1 . To test this prediction, we compared the effects of DPTHF on these two heat-evoked current responses. When we superimposed 100 µM DPTHF on heat after inducing I 1 , we observed an initial increase in both inward and outward current. This potentiation by DPTHF, defined as the difference between the maximum current amplitudes measured before and during DPTHF application (Fig. 7C, points a to b) , was 214.6 ± 56.2% and 466.3 ± 164.5% at +80 mV and -80 mV, respectively (n = 18). In contrast, when DPTHF was applied after the I 2 transition, there was an immediate reduction in current amplitude (35.2 ± 3.2% and 16.7 ± 1.6% at -80 and +80 mV, respectively; n = 6, p < 10 -3 at ±80 mV, Fig. 7D ) that was comparable in size to the "low potency" (150-230 µM IC 50 ) component of inhibition of DPBA-evoked currents by DPTHF (Fig. 3D) . Inhibition of the I 2 currents reversed rapidly upon DPTHF washout. These findings suggest that, following the I 2 transition, DPTHF can, indeed, block TRPV3 currents and that the immediate effects of DPTHF on I 1 and I 2 are distinct. Interestingly, however, even when DPTHF was applied prior to the appearance of the heat-evoked I 2 transition, its potentiation of currents was followed after ~30 sec by inhibition (49.6 ± 7.0% and 52.3 ± 7.9% at +80 mV and -80 mV, respectively, calculated as the difference between the maximum and minimum amplitudes recorded during DPTHF stimulation, n = 18, Fig. 7C , points b to c). Furthermore, upon drug washout, there was a significant rebound in current at positive and negative potentials, along with a linearization of the I -V relationship.
Thus, at elevated temperatures, DPTHF appears to have both channel potentiation and channel block capabilities. Indeed, when applied during I 1 , DPTHF may even facilitate the heat-evoked I 2 transition, such that potentiation is followed by block.
Another noticeable characteristic of I 2 was that, as in the case following DPBA washout, current deactivation upon return to the room temperature was less complete than after I 1 (residual current 30 s after returning to room temperature: 25.0 ± 3.2% and 48.3 ± 2.6% (n = 7) of maximal heat-evoked current at -80 and +80 mV, respectively versus 7.4 ± 2.5% at -80 mV, p < 10 -3 , 6.6 ± 1.7% at +80 mV, p < 10 -7 , n = 7, in cells showing no I 2 transition). This residual current was not due to leak or poor recording conditions, because 10 µM RR reduced it by 32.4 ± 5.9% and 62.7 ± 7.5% at +80 and -80 mV, respectively (n = 6, p < 0.01, paired t test) (not shown). NMDG also decreased the residual inward current by 72.3 ± 5.0% (n = 12, p < 10 -5 , paired t test) and hyperpolarized E rev by 15.7 ± 1.7 mV (n = 12). Moreover, this residual component was suppressed when the bath temperature was decreased to 15 °C (80.4 ± 2.7% inhibition at +80 mV, p < 10 -3 ; 60.9 ± 7.4% inhibition at -80 mV, p < 0.01; n = 6, paired t test, Fig. 8A ), demonstrating the temperature sensitivity of these currents and suggesting that the I 2 transition might change the temperature-dependence of TRPV3. In order to address this possibility directly, we applied pairs of identical temperature ramps (15 to 50 °C in 30 seconds) before and after induction of I 2 with a 2 minute 50 °C stimulation. We then plotted the temperature-current relationships of the second and fifth heat-evoked TRPV3 current responses (Fig. 8B heat stimuli a and b) . The temperatureresponse plot of heat-evoked I 1 currents was characterized by an extremely shallow phase, followed by a much steeper phase that began at 32.8 ± 1.4 °C, (Fig. 8C , traces a, n = 6), consistent with previous reports (3) (4) (5) . In contrast, I 2 currents exhibited a less steep temperature-response relationship through the entire temperature range, with an apparent threshold of < 20 °C (Fig. 8C , traces b, n = 6). In order to distinguish whether this shift in temperature responsiveness was a unique consequence of prolonged heating or more generally associated with the transition between two phases, we examined the temperature response profiles of cells expressing TRPV3 before and after exposure to a high concentration (320 µM) of DPBA. To fairly compare cells in each phase we applied DPBA to TRPV3-expressing cells for 1 minute and separated current responses into two groups. We classified the cells that exhibited robust currents upon DPBA washout with a linear I-V relationship, as well as residual currents, as the I 2 -like group (Fig. 8E, G, n = 6 ) and cells that did not do so as the I 1 -like group (Fig. 8D, F , n = 6). Following current stabilization after DPBA washout, we reduced the bath temperature from ~25 °C to 15 °C. Such cooling led to a reduction in residual current amplitudes of the I 2 -like group by 87.1 ± 3.3% at +80 mV (p < 0.001, n = 6, paired t test) and 88.7 ± 3.6% at -80 mV (p < 0.01, n = 6, paired t test). Cooling had no clear effect on the I 1 -like group. At this point, we applied a heat ramp (15 to 50 °C in 30 seconds, Fig. 8D , E, stimuli c and c´) and plotted temperature-current relationships. The I 1 -like group (Fig. 8H, traces c) exhibited steep temperature-dependence above 32.1 ± 1.2 °C (n = 6), with little temperature-dependence at lower temperatures. In contrast, the I 2 -like group (Fig.  8H , traces c´) exhibited a less steep temperature response profile, with an apparent threshold of < 20 °C (n = 6) as observed in cells exhibiting a heat-evoked I 2 (Fig. 8C) . These results suggest that thermal and chemical agonists induce a similar biphasic transition in TRPV3 activity that is not readily reversible after agonist removal. They further suggest that thermal denaturation is not an adequate explanation for this transition, since DPBA can partially replicate the effect of heat.
Since the heat activation of TRPV1 was recently proposed to be voltage-dependent (9), we examined the voltage-dependent properties of I 1 and I 2 of TRPV3. It was difficult to test voltagedependence during a continuous temperature ramp because TRPV3 shows time-dependent sensitization at sustained elevated temperature, preventing one from reaching an acceptable steady-state. Moreover, to attain I 2 using a continuous temperature ramp, we had to elevate the temperature to > 55 °C, a range over which the temperature ramp was not linear in our experimental setup. As an alternative approach, we therefore evaluated the voltage-dependence of sensitizing currents by repetitively applying identical 45 °C stimuli. We initially monitored current amplitudes using a voltage-ramp protocol before, during and between heat stimuli (Fig. 9A) . (Fig. 9B) . We measured the steady-state current (I ss ) amplitude at the end of the test step-pulses to obtain the I-V relationship (Fig.  9D ) and at the beginning of the tail current (I tail ) induced by the +60 mV pulse to compare voltagedependence of activation (Fig. 9E ). When this protocol was applied at room temperature, little current was recorded, yielding a flat I-V relationship over the voltage range tested for both I ss and I tail (Fig. 9B, point a) . At 45 °C, the currents activated by the step-pulse protocol showed time-dependent properties similar to those described for TRPV1 and TRP-melastatin 8 (TRPM8) (9,29,30)-an abrupt increase followed by a slow decrease at hyperpolarizing potentials and a slow increase to a plateau at depolarizing potentials (Fig. 9B, point b) . This timedependence resulted in a strongly outward rectifying I ss -V relationship which was comparable to that obtained from the ramp pulse protocol. I tail exhibited an increase in amplitude with depolarization that approached a plateau at extremely depolarizing potentials. Fitting of the I tail -V relationship to a Boltzmann function allowed us to calculate a half-maximal activation voltage (V 1/2 ). Although we could not relate V 1/2 directly to temperature in our experiment, the V 1/2 was correlated with the heat-evoked current density (I ss measured at +80 mV divided by membrane capacitance). That is, as the current density decreased, V 1/2 became more depolarized, whereas as the current density increased, V 1/2 shifted to more hyperpolarized potentials (Fig. 9G) . Even in a given cell, as the current sensitized with repetitive heat stimulation, V 1/2 became more hyperpolarized as exemplified in Fig. 9G (filled dots). These results suggest that TRPV3, like TRPV1 and TRPM8, exhibits voltage-dependent activation properties, and that repeated heat stimulation shifts its voltage-dependence to promote greater channel activity.
Repetitive heat stimulation also allowed us to observe a transition to I 2 , identified by a steep increase in current and a linearization of the I ss -V relationship comparable to that observed upon heating during the ramp-pulse protocol. Under these conditions, two to seven (4.3 ± 0.5, n = 10) heat stimuli were necessary to achieve the I 2 transition. In contrast to I 1 , I 2 showed weaker timedependent current inactivation at hyperpolarizing potentials and weaker time-dependent current increase at depolarizing potentials (Fig. 9B , trace c). In fact, there was a tendency towards I 2 desensitization or inactivation at strongly depolarizing potentials. These changes occurred gradually during the transition period from I 1 to I 2 , as exemplified in Fig. 9C , in which a two-step protocol (+80 mV followed by -80 mV for 100 ms each) was repeated during this transition period. Another noticeable difference was that the I tail amplitude was much larger in I 2 (441.4 ± 50.4 pA/pF at -120; 414.9 ± 37.7 pA/pF at +180 mV) than in I 1 (52.6 ± 6.5 pA/pF at -120 mV, p < 10 ; n = 10; Fig. 9E, F) . In addition, the I tail -V relationship did not show a sigmoidal increase with more depolarized test voltages. Instead, it was almost flat, with only a slight decrease at strong depolarizing potentials. These factors prevented us from calculating a V 1/2 for I 2 . To compare the voltage-dependence of I 1 with that of I 2 , we averaged the I tail -V relationships from multiple traces recorded during I 2 and during the trial period just prior to the I 2 transition (Fig. 9F) . I 1 showed clear voltage-dependent activation behavior, with a mean V 1/2 value of +80.7 ± 4.0 mV and k of 31.7 ± 1.3 mV (n = 10). Upon restoration of the bath to room temperature, the current amplitudes decreased, but failed to recover fully to baseline levels, consistent with our previous observation. During step changes in voltage, these residual currents showed timedependent properties, like I 1 , but exhibited apparently slower activation and inactivation kinetics (Fig. 9B) . Residual current I tail also showed voltage-dependence, with a V 1/2 of 38.7 ± 7.3 mV and k of 36.6 ± 1.9 mV (n = 10) that was much more hyperpolarized than that of I 1 . Thus, voltage-dependence is not permanently eliminated by the I 2 conversion.
To explore the potential mechanistic basis of the I 1 to I 2 transition, we hypothesized that these two response patterns might reflect initial inhibition by divalent cations (DVC) and subsequent loss of that inhibition, following prolonged or repetitive heat stimulation. To test this hypothesis, we alternated between standard bath solution and a nominally divalent cation free (DVF) solution, at 15 to 20 s intervals, while maintaining bath temperature at 43 to 46 °C. This protocol allowed us to compare time-dependent changes of heat-evoked current amplitudes in the presence versus absence of DVC in the same cell. Outwardly rectifying currents were evoked by heat stimuli in the presence of Ca 2+ and Mg 2+ . However, current amplitudes were much larger in both the inward and outward directions under DVF conditions (Fig. 10A) . When DVC were restored, the currents dropped to an amplitude just slightly higher than the previous DVC level, consistent with the possibility of DVC inhibition of heat-evoked currents. In cells exhibiting a low current density, outward rectification was also observed during the earliest DVF trials, but lost over time (data not shown). During a continuous heat exposure, currents recorded under DVF conditions sensitized over time, but typically attained a plateau level after 1 to 3 DVF trials that was maintained at the same level or decreased slightly during protracted stimulation (Fig. 10A) . In all cases, however, the I-V relationship showed a rectification ratio of ~1 once the current amplitude reached plateau. These DVF current profiles were similar to the I 2 currents recorded under DVC-containing conditions, described above. However, this does not necessarily mean that the I 2 transition had already occurred in these cells because even after the current amplitude had achieved its maximum under DVF conditions, DVC replacement could still inhibit the current. Moreover, sensitization continued very slowly during subsequent DVC trials, despite no further current increase in the absence of DVF. (Fig 10A) . When currents were normalized to the maximum value for a given cell, clear sensitization of heatevoked currents and inhibition by DVC were observed over the first four trials (Fig. 10C) . In addition, the inhibition by DVC was voltagedependent; the relative current amplitudes at positive potentials were bigger than those at negative potentials (Fig. 10D) , resulting in outward rectification of heat-evoked currents. Following a gradual increase in the presence of DVC, at some point a steep current amplitude increase was observed between DVF trials (arrow in Fig. 10A) , which resembled the heat-induced I 2 transition described above. Even after the occurrence of this event, the current amplitudes under DVF conditions showed little change compared to values obtained in the previous trial. However, restoration of DVC to the bath no longer produced strong current inhibition after such a transition. During repeated DVC trials, every cell showed a tendency towards decreasing DVC inhibition, although the rate of reduction was variable (Fig. 10E) . By the 7 th DVF trial ~50% (8/15) of cells showed an I 1 to I 2 transition, defined here as a reduction in the extent of DVC inhibition to less than 30% (Fig. 10 E, F) .
If the I 1 to I 2 transition is truly related to DVC inhibition, mutation of putative DVC binding residues in the TRPV3 pore loop would be expected to alter the relative ease with which this transition can be evoked. To test this hypothesis, we mutated an acidic residue D641 of TRPV3, located in the putative pore loop region, to asparagine (D641N). This negatively charged residue is conserved among TRPV1, TRPV2, TRPV3, and TRPV4 and is postulated to contribute to a DVC binding site (27, 28) . Neutralization of this residue has been reported to reduce RR sensitivity (27, 28) , DVC permeability (27, 28) , Ca 2+ inhibition and outward rectification (27) in these channels. In HEK 293 cells, TRPV3 D641N formed a functional channel responsive to DPBA and heat. When this mutant was tested using the alternating DVC/DVF protocol, it showed a pattern of heat-evoked current development and inhibition by DVC that was qualitatively similar to that of wild-type TRPV3 (Fig. 10B) . Indeed, under DVF conditions, mutant and wild-type heat-evoked currents were similar in amplitude (TRPV3, -1.3 ± 0.2 nA/pF, n = 15; D641N, -1.2 ± 0.1 nA/pF, n = 15, -60 mV, p > 0.7). However, under DVC conditions, mutant currents were significantly larger than those of wild-type TRPV3, suggestive of impaired DVC inhibition (Fig. 10C) . DVC current inhibition was also voltage-dependent in D641N. However, the differences in relative currents between -60 and +60 mV became smaller with successive DVF trials (Fig. 10D) . Temporal trends in DVC inhibition also differed between mutant and wildtype TRPV3 (Fig. 10E) . Although nearly half of cells expressing wild-type TRPV3 failed to exhibit a loss of DVC inhibition by the 7 th DVF trial, within 6 DVF trials, DVC inhibition was reduced to < 30% in every D641N-transfected cell tested (Fig. 10E, n = 15) . Indeed, when we plotted the cumulative incidence of loss of DVC inhibition as a function of DVF trial number, cells expressing D641N were more likely to have undergone an I 2 transition than cells expressing wild-type TRPV3 at every DVF trial (Fig. 10F) . These results support the idea that DVC inhibition in the TRPV3 pore region is related to the I 2 transition.
Finally we asked whether the TRPV3 I 2 transition could be observed in a native cell context. We have previously shown that TRPV3-like responses can be recorded from skin keratinocytes when 2-APB is applied at high temperature (12) . We therefore attempted to evoke I 2 in this setting. As previously described for heat and 2-APB (12), heat alone or DPBA (100 µM) alone evoked little or no TRPV3-like current in most cells under these conditions, whereas superimposition of the two stimuli produced supra-additive activation of a TRPV3-like current (-16.2 ± 4.8 pA/pF and 75 ± 13.2 pA/pF at -80 and +80 mV, respectively). Thus DPBA can sensitize heat-evoked currents mediated by native TRPV3. Despite persistent heating in the presence of DPBA, however, no apparent conversion to I 2 was observed.
Rather, current amplitudes decreased slightly after reaching a peak, as observed in TRPV3-transfected HEK 293 cells with low current density (Fig. 11A ). Because the current density in the keratinocytes under these conditions was much smaller than the range over which TRPV3 showed I 2 in HEK 293 cells, we attempted to increase native TRPV3 expression levels by modifying our culture conditions (described in Methods). However, even with these modifications, we failed to observe currents of a sufficient density to permit the I 2 transition, even when we used a bath solution containing 100 µM Ca 2+ to reduce the DVC inhibition (data not shown). Therefore we resorted to increasing the TRPV3 current density by transiently transfecting keratinocytes with the mouse TRPV3 cDNA. GFP-positive keratinocytes transfected with control vector (pTracer) exhibited little or no heatevoked TRPV3-like current (Fig. 11B) . However, mouse TRPV3-transfected keratinocytes exhibited robust heat-evoked currents upon co-application of 1 µM DPBA and heat. In 7 out of 10 of these cells, during 5 minutes of continuous heat stimulation, an I 2 conversion was evident, as indicated by an abrupt increase in inward and outward current amplitude and loss of outward rectification ( Fig. 11C and D) . Thus, while our culture conditions do not permit us to observe an I 2 transition mediated by native TRPV3, these data indicate that keratinocytes are capable of supporting this transition, and that it is therefore not a phenomenon specific to HEK 293 cells.
DISCUSSION
We have shown that DPBA, like 2-APB, can activate TRPV3 to produce outwardly rectifying currents that sensitize with repeated drug exposure. One minor difference between these two compounds was in the degree of desensitization they produced at higher concentrations. Whereas DPBA-evoked currents desensitized markedly at all concentrations > 100 µM, desensitization in response to 2-APB was apparent only at the highest concentration tested, 1 mM. This desensitization phenomenon skewed the DPBA concentration-response profile at high concentrations and likely resulted in an underestimate of this compound's true efficacy, which may be slightly greater than that of 2-APB. A similar sequential pattern of potentiation followed by inhibition was previously reported for the action of 2-APB on native calcium-release activated calcium channels in several leukocytic cell lines (21) . In that case, as in the present study, enhancement of channel activity was most evident at low concentrations, whereas inhibition dominated at higher concentrations.
Unlike the other two diphenyl compounds, DPTHF failed to activate TRPV3 at room temperature. Instead, this compound inhibited current responses and Ca 2+ influx evoked by DPBA or 2-APB, even when added after current development. Interestingly, this inhibitory effect appeared to consist of at least two components with different potencies, suggesting that DPTHF might inhibit TRPV3 via more than one mechanism or site of action. Whereas the three diphenyl-containing compounds used in this study, 2-APB, DPBA and DPTHF, have all been shown to inhibit store-operated Ca 2+ influx (18), not all actions of these drugs are the same. For instance, DPTHF is ineffective at blocking volumeregulated anion channels (24) . The structural basis for these differences is unclear, but could relate to the absence of a boron atom in DPTHF or to the tendency of 2-APB (but not DPTHF) to form dimers that resemble DPBA (18) . We also cannot formally exclude the possibility that other derivatives of these compounds account for their activities at TRPV3. Further structure-activity studies will be required to explain these differences, to define the site(s) of action of these compounds, and to determine whether they might serve as templates for the development of highaffinity TRPV3-selective agonists or antagonists. Another key finding of the present study was that robust TRPV3 stimulation with either chemical or thermal agonists evoked a kinetically biphasic activation profile. The secondary phases evoked by DPBA and heat share many common features. Both involve an abrupt increase in inward and outward current amplitude, a rapid transition from an outwardly rectifying I-V relationship to a linear one, a significant residual current at 25°C following agonist removal, and a shift in the temperature-response profile towards cooler temperatures. Of the two, the chemically activated biphasic current response was more complicated, since the second phase of activation was invariably followed by apparent channel block and a transient current increase during drug washout (Fig. 4A) . We therefore focused the remainder of our analysis on the heat-evoked biphasic response, which was kinetically simpler. Indeed, a remarkable feature of the heat-evoked I 1 to I 2 conversion was that, although its onset time varied between cells, once initiated, it progressed with very a uniform timecourse.
Several mechanisms can be postulated to explain the I 1 to I 2 conversion. For example, this change could, conceivably, result from agonistand time-dependent modulation of the TRPV3 protein by cellular events such as phosphorylation (31, 32) , Ca 2+ and/or calmodulin binding (27, 33, 34) , or phosphoinositide release (35, 36) . We also cannot exclude the possibility that a sudden increase in TRPV3 channel density at the plasma membrane contributes to this conversion processes. However, a quantitative increase in TRPV3 channel number, alone, appears insufficient to explain the conversion from I 1 to I 2 , given the qualitative changes in current response associated with this transition and the lack of difference between current amplitudes recorded under DVF conditions in the period just before versus after the I 2 conversion. A third possible mechanism is suggested by the report that the temperature-dependent activities of TRPV1 and TRPM8 can be explained, at least in part, by the effects of temperature on voltage-dependent channel gating (9) . In our present study, we found that, at least during the I 1 phase, TRPV3 also exhibited voltage-dependent gating. Moreover, a key feature of I 1 was a gradual shift in V 1/2 in the hyperpolarized direction with repetitive heat stimulation. This shift may be sufficient to explain both the gradual increase in current, and the gradual decrease in rectification ratio that are observed during I 1 , even in the absence of DVC (not shown). As with TRPV1 and TRPM8 (9), the underlying mechanism of voltage-dependence is completely unclear. Upon transition to I 2 , there is both a loss of obvious TRPV3 voltage-dependence and an enhancement of the maximal current amplitude across voltages. We cannot determine whether the "flattening" of the voltage-response profile reflects a complete loss of voltagedependence or an extremely hyperpolarizing shift. The relatively hyperpolarized voltage-dependence of the post-I 2 residual currents provides support for the latter possibility. However, some process besides voltage-dependent gating still needs to be invoked to explain the dramatic shift in maximal current amplitude to levels that greatly exceed the maximal current observed in I 1 .
A fourth possible explanation for the I 2 conversion is that it reflects underlying changes in the TRPV3 channel pore. This notion is supported by the following differences between I 1 and I 2 : 1) RR, which has been shown to interact with the pore regions of TRPV1 (28) and TRPV4 (27) , enhances outward TRPV3 I 1 , but inhibits outward I 2 ; 2) NMDG permeability is greater in I 2 than in I 1 ; 3) The ratio of P Ca to P Na is lower in I 2 than in I 1 ; 4) The secondary I 2 -like current evoked by DPBA is invariably followed by DPBA block; and 5) The I 2 conversion permits DPTHF block to be observed without preceding DPTHF-evoked potentiation.
Additional evidence that changes in the TRPV3 pore may underlie the I 2 conversion comes from our divalent cation experiments. Removal of these ions masks our ability to differentiate between I 1 and I 2 . Indeed, during prolonged exposure to heat under DVF conditions, while there is a brief initial period of outward rectification that may be due to voltage-dependent channel gating (data not shown), TRPV3 exhibits I 2 -like currents soon after the application of heat. However, the mechanisms underlying both the gradual sensitization of I 1 currents (Fig. 10A ) and the more abrupt conversion from I 1 to I 2 (defined as the absence of both rectification and current inhibition upon restoration of DVC, data not shown) appear to proceed even during DVF trials. One interpretation consistent with these findings is that voltage-dependent block of monvalent cationic currents by DVC and activationdependent loss of this block are responsible for the dramatic transition from I 1 to I 2 . Further support for this idea comes from our observation that mutation of a putative DVC binding residue (D641) in the TRPV3 pore region diminishes the difference between currents in the presence versus absence of DVC and allows the I 2 conversion to become apparent after a shorter number of DVC trials. It should be noted, however, that the partial nature of the D641N mutant deficit suggests the existence of additional DVC inhibition sites in the TRPV3 pore, as observed in TRPV4 (27) .
What might be the physical nature of pore changes associated with the I 2 conversion? One obvious possibility is a progressive agonist-and time-dependent dilatation of the TRPV3 channel pore. This model is based on the notion that DVC initially block the channel by interacting with acidic residues lining the channel pore. An analogous situation is observed with structurally homologous cyclic nucleotide-gated channels, in which one Ca 2+ ion binds to acidic residues lining the tetrameric channel pore to block monovalent cationic currents through the channel (37) . As the TRPV3 pore progressively dilates, however, we hypothesize that a critical point is reached at which the DVC can no longer interact with their binding sites, resulting in relatively abrupt loss of voltage-dependent block, enhanced monovalent cationic current amplitude and loss of outward rectification. The progressive element of this model also addresses another complexity of our findings. For the sake of simplicity, we have treated the sudden changes in current amplitude and rectification ratio as coincident with the changes in RR sensitivity, NMDG permeability, and block by diphenyl compounds. However, these changes may reflect different degrees of pore dilatation and therefore become evident on different timescales. It is also noteworthy that, although the changes we observe in current amplitude and rectification ratio may result directly from loss of DVC blockade, it is unclear whether DVC binding influences either these other pore-related characteristics of TRPV3 currents or the voltage-dependence of channel gating.
Although the model outlined above remains highly speculative, it is not without precedent. Many channels exhibit activitydependent changes in ionic permeability (38) . One informative example is the progressive pore dilatation observed upon continuous agonist occupancy of the ATP-gated ion channels, P2X 2 , P2X 4 , and P2X 7 (38) (39) (40) . These changes occur over a timescale of seconds (39, 40) and are associated with a switch from inwardly rectifying to linear I-V relationship (41). Extracellular Ca 2+ is also important in this transition, though its exact role is unclear (40) . The best evidence for progressive pore dilatation of P2X channel has come from dynamic studies of organic cation permeability (39, 40) . Interestingly, the ionic permeability change of P2X 2 , like that of TRPV3, has recently been found to depend on current density (41). In both cases, the basis of this dependence remains unclear, though it might reflect either a requirement for interaction between channels on the cell surface or rate-limiting amounts of cellular constituents that prevent the I 2 conversion. In any case, dynamic biophysical assessments of TRPV3 ion permeability and pore accessibility may indicate whether this channel undergoes structural changes similar to those reported for P2X channels.
Might other temperature-gated TRP channels undergo activity-dependent changes similar to those exhibited by TRPV3? In fact, exposure of recombinant TRPV1 or TRPV2, expressed in Xenopus oocytes, to consecutive heat stimuli results in a shallowing and shift in temperature response profile analogous to that seen during the TRPV3 I 2 conversion (2). Moreover, prolonged exposure to temperatures > 50°C can produce a similar stable shift in the temperature-response profile of native TRPV1 in sensory neurons (42) . This change was interpreted as reflecting thermal denaturation of TRPV1 (42) . However, at least in the case of TRPV3, a nonthermal stimulus, DPBA, produces a similar effect at room temperature (Fig. 8) . In addition, TRPV1 exhibits permeability to H 3 O + ions, NMDG , and the large organic cationic dye, FM1-43, following activation by capsaicin (43, 44) . While the kinetics of acquisition of permeability to large cations have not been explored in detail, it is possible that TRPV1, too, undergoes agonist-and time-dependent pore changes that are simply more rapid than those in TRPV3, and therefore more difficult to detect.
Furthermore, TRPV1 desensitization during prolonged heating may mask such changes.
We were unable to observe an I 1 to I 2 conversion in native TRPV3 in cultured keratinocytes. This is likely due to the low TRPV3 current density in these cells that may result from TRPV3 downregulation in culture (5). However, increasing the TRPV3 expression level in keratinocytes by transfection allowed us to recapitulate the I 2 conversion upon stimulation with heat and a low concentration of DPBA. Thus, keratinocytes provide a permissive environment for this conversion. Given the existence of an extracellular Ca 2+ gradient in the epidermis and the dependence of keratinocyte differentiation on this ion (45), if prolonged heating produces an I 2 conversion in vivo, this change might impact either the sensory consequences of prolonged skin heating or the course of epidermal repair after burn injury. Such effects could be exaggerated under conditions where surface TRPV3 expression is upregulated. F. Relationships between test voltages and averaged I tail current densities recorded prior to heat stimulation (pre, n = 5 cells), during I 1 (n = 10), during I 2 (n = 10) or after return to room temperature (post, n = 10). G. Relationship between half-maximal potential (V 1/2 ) and I ss density (I ss at +80 mV normalized to membrane capacitance). V 1/2 was obtained by fitting of I tail to a Boltzmann function, as described in Methods. 34 points were derived from 12 cells. Filled circles were derived from one cell exposed to 3 consecutive heat stimuli (as numbered) prior to I 2 transition. Arrow indicates the I ss -V 1/2 relation of the current b in panel B. Solid line was derived from linear regression of all points. , was switched to a nominally divalent cation-free (DVF) solution during the indicated periods. Arrows indicate abrupt current increases in the presence of DVC. All traces were derived using the voltage-ramp protocol. DVC and DVF trials were alternated repetitively during constant heat stimulation until I 2 conversion was observed. Horizontal dashed lines indicate zero current level. C. Reduced DVC inhibition in D641N mutant. Current amplitudes recorded at -60 mV in panels A and B were normalized to the maximal value in each recording, averaged, and plotted against the number of DVF trials. Data are shown only for the first four DVF trials. Open symbols, wild-type TRPV3 (n = 12-15); filled symbols, TRPV3 D641N (n = 7-15); circles, DVC; squares, DVF. *, p < 0.05; **, p < 0.01, wild-type versus D641N. D. Voltage-dependent DVC inhibition of TRPV3 and TRPV3 D641N. Currents at +60 mV (triangles) and -60 mV (squares) were normalized to the maximal current in each recording, averaged, and plotted against the number of DVF trials. Open symbols, wild-type TRPV3 (n = 12-15); filled symbols, TRPV3 D641N (n = 7-15). *,p < 0.05; **, p < 0.001; ***, p < 10 -4
; currents at +60 mV versus those at -60 mV, paired t test). E. Percent inhibition by DVC, as a function of DVC trial number. This value was calculated at -60 mV as the percent decrease in current amplitude from the peak amplitude during a given DVF trial to the minimum amplitude during the subsequent DVC trial. Solid lines, wild-type TRPV3 (n = 15); dotted lines, TRPV3 D641N (n = 15). F. Cumulative incidence of cells exhibiting an I 2 transition, as a function of DVF trial number. Solid line, wild-type TRPV3, dotted line, TRPV3 D641N. Fig. 11 . Recombinant TRPV3 can exhibit biphasic currents in primary mouse keratinocytes A. Representative native currents at ±80 mV, recorded using the voltage-ramp protocol, from mouse primary keratinocytes exposed to repetitive heat stimuli in the presence of 100 µM DPBA. Currents were recorded using 'low Cl -pipette' and 'low Cl -bath' solutions defined in the Methods. B, C. Current amplitudes at ±80 mV recorded from mouse keratinocytes transfected with pTracer vector (B) or mouse TRPV3 (C) during concurrent stimulation with heat and 1 µM DPBA. D. Current-voltage relationships recorded during voltage-ramp pulse from -100 mV to +100 mV at the time points indicated in panel C. Table 1 . Comparison between initial (I 1 ) and secondary (I 2 ) heat-evoked TRPV3 current responses. -------------------------------------------------------------------------------------------------------------- Figure 11 
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